Physician profile
Lisa D Holmes
NPI 1871550798
$6,735.45
in general payments reported to CMS, 2019-2025
31 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what 87% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,629 · 2020: $266 · 2021: $341 · 2022: $858 · 2023: $1,274 · 2024: $1,292 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,642.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,642.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,379.46 | 2019-2025 | |
| Amgen INC. | $610.48 | 2019-2025 | Evenity, Prolia |
| Lilly USA, LLC | $596.45 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $452.93 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Allergan, INC. | $416.78 | 2019-2020 | |
| Glaxosmithkline, LLC. | $415.47 | 2019-2025 | Bexsero, Shingrix, Arexvy |
| Gilead Sciences, INC. | $349.75 | 2019-2024 | Epclusa |
| Coopersurgical, INC. | $340.72 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $277.18 | 2019-2025 | Capvaxive, Gardasil 9, Gardasil |
| Pfizer INC. | $206.41 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.80 | 2019-2020 | |
| Horizon Therapeutics Plc | $170.11 | 2020-2021 | |
| Exact Sciences Corporation | $167.33 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Teva Pharmaceuticals USA, INC. | $164.20 | 2019-2020 | |
| Amarin Pharma, INC. | $147.27 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $135.30 | 2024 | Freestyle Libre 3 |
| Edwards Lifesciences Corporation | $113.14 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Arbor Pharmaceuticals, INC. | $110.71 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.73 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $88.20 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.03 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.41 | 2019-2023 | Trintellix |
| Shire North American Group INC | $29.46 | 2019 | |
| Astellas Pharma US INC | $21.51 | 2019 | |
| Idorsia Pharmaceuticals US INC | $20.77 | 2023 | Quviviq |
| Ironwood Pharmaceuticals, INC | $20.00 | 2019 | |
| Phathom Pharmaceuticals, INC. | $19.05 | 2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $19.05 | 2023 | Camzyos |
| Ibsa Pharma INC. | $16.53 | 2023 | Tirosint, Licart |
| Xeris Pharmaceuticals, INC. | $14.20 | 2025 | Gvoke Hypopen |
| Amneal Pharmaceuticals LLC | $14.02 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.